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Abstract: The epithelial-mesenchymal transition (EMT) comprises an important biological mech-
anism not only for cancer progression but also in the therapeutic resistance of cancer cells. While
the importance of the protein abundance of EMT-inducers, such as Snail (SNAI1) and Zeb1 (ZEB1),
during EMT progression is clear, the reciprocal interactions between the untranslated regions (UTRs)
of EMT-inducers via a competing endogenous RNA (ceRNA) network have received little atten-
tion. In this study, we found a synchronized transcript abundance of Snail and Zeb1 mediated by
a non-coding RNA network in colorectal cancer (CRC). Importantly, the trans-regulatory ceRNA
network in the UTRs of EMT inducers is mediated by competition between tumor suppressive
miRNA-34 (miR-34) and miRNA-200 (miR-200). Furthermore, the ceRNA network consisting of
the UTRs of EMT inducers and tumor suppressive miRs is functional in the EMT phenotype and
therapeutic resistance of colon cancer. In The Cancer Genome Atlas (TCGA) samples, we also found
genome-wide ceRNA gene sets regulated by miR-34a and miR-200 in colorectal cancer. These results
indicate that the ceRNA networks regulated by the reciprocal interaction between EMT gene UTRs
and tumor suppressive miRs are functional in CRC progression and therapeutic resistance.
Keywords: ceRNA; epithelial mesenchymal transition; Snail; ZEB1; colorectal cancer; therapeutic
resistance
1. Introduction
The epithelial-mesenchymal transition (EMT) comprises an important biological pro-
gram involving development and cancer progression [1]. While earlier EMT studies had
focused on phenotypic conversion from an epithelial to a mesenchymal state, recent evi-
dence indicates that EMT plays a critical role in cancer stemness, metabolic reprogramming,
immune evasion, inflammation and therapeutic resistance of cancer cells [2]. Snail (SNAI1)
and ZEB1 are well-known inducers of cancer EMT, and their protein abundance is tran-
scriptionally or post-translationally regulated by many oncogenic signaling pathways, such
as canonical Wnt and TGF-β [3–6].
MicroRNAs (miRs) are ubiquitous post-transcriptional regulators that impact RNA
stability and the rate of translation by pairing to complementary sites within target
RNAs [7–10]. The UTRs of Snail and Zeb1 are targeted by tumor suppressive miR-34a
and miR-200, respectively [11]. Typically, an miR binding to an untranslated region (UTR)
represses the protein translation of mRNA. In turn, the UTRs of mRNA transcripts have an
miRNA-binding motif suppress protein expression in cis-regulation. However, the compet-
ing endogenous RNA (ceRNA) hypothesis posits an inverse role for the UTRs involving
the trans-regulatory crosstalk of UTRs through common miRs shared and sequestered by
competing RNAs [12,13]. According to the ceRNA hypothesis, non-coding RNAs (such as
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UTRs, long non-coding RNA (lncRNA) and pseudogenes) regulate other RNA transcripts
by competing for shared miRs. For example, PTEN and VCAN share miR-136 and miR-144
binding sites in their UTRs and, therefore, compete for these miRNAs, resulting in an RNA
interaction between PTEN and VCAN [12,13]. Therefore, the ceRNA hypothesis provides
a novel layer of RNA transcript interaction via miRNA competition independent of its
protein coding function. We have previously reported that the overexpression of Wnt
gene UTRs, including Wnt1, LRP6, CTNNB1 (beta-catenin) and Snail UTRs, with miR-34a
binding sites increased the endogenous Snail expression [3,14,15], suggesting the existence
of a cis- and trans-regulatory network between UTRs sharing miR-34a binding sites [16].
Although the ceRNA hypothesis provides an interesting role for an miR and non-
coding RNA, including UTRs, pseudogenes, antisense transcripts and long non-coding
RNA, ceRNA regulatory networks in EMT genes are not well-known. In this study, we
found a synchronous abundance of Snail and Zeb1 transcripts in human cancer samples and
an inverse abundance between tumor suppressive miR-34a and miR-200 to EMT inducers.
Although Snail’s UTR does not have an miR-200 binding site, we found an indirect ceRNA
interaction between the UTRs of EMT inducers and tumor suppressive miRs. Further, the
UTRs of EMT inducers or tumor suppressive miRs play a role in the therapeutic resistance
of colorectal cancer cells. Our results suggest not only that a novel ceRNA network between
Snail and Zeb1 is regulated by miR-34a and miR-200, but, conversely, that the non-coding
EMT gene UTRs dynamically regulate the tumor suppressive miRs.
2. Results
2.1. Coincident Snail and Zeb1 Transcript Abundance in Human Cancer
While Snail and Zeb1 constitute key EMT inducers, their relative transcript abundance
in human cancer samples has not been well-studied. Examining Snail and Zeb1 transcripts
in The Cancer Genome Atlas (TCGA) samples, we found their abundance to be significantly
correlated in COADREAD (colorectal cancer), and that patients with a high abundance
of Snail and Zeb1 show poor survival prognosis (Figure 1a), as do patients with a high
abundance of either Snail or Zeb1 (Figure S1a). We also found a concordant abundance of
Snail and Zeb1 transcripts in BRCA (breast cancer), LUAD (lung adenocarcinoma), LUSC
(lung squamous cell carcinoma) and HNSC (head and neck squamous cell carcinoma)
samples (Figure S1b), suggesting crosstalk between the Snail and Zeb1 transcripts in
human cancer.
Exploring the hypothesis that Snail and Zeb1 show accordant transcript abundance,
we chose HCT116, a colorectal cancer cell line with high expression levels of Snail and
Zeb1. A knockdown of Snail or Zeb1 downregulates the endogenous protein and mRNA
transcript levels of Zeb1 and Snail, in tandem (Figure 1b,c). To determine whether the
reciprocal regulation between Snail and Zeb1 is independent of the protein level, we next
generated protein-coding null cells for Snail and Zeb1 with CRISPR-Cas9 in HCT116 cells
(Figure S1c,d). As expected, Snail and Zeb1 null cells showed epithelial phenotypes by
means of increased E-cadherin expression, decreased migratory potential and increased
susceptibility to paclitaxel compared to parental HCT116 cells (Figure S1e,f). To examine
the crosstalk between the Snail and Zeb1 transcript independent of the protein-coding
function, we knocked down the Snail or Zeb1 transcript with siRNA in Snail or Zeb1 null
cells and determined their transcript levels (Figure 1d). Indeed, the knockdown of the Snail
or Zeb1 transcript suppressed the other in those null cells, suggesting crosstalk between
the Snail and Zeb1 transcripts via non-coding interactions, such as UTR and miR.
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Figure 1. Concordant transcript abundance of Snail and Zeb1: (a) A supervised hierarchical clustering based on Snail and
Zeb1 expression profiles (left upper panel) and Pearson correlation scatter plots of Snail and Zeb1 transcript in colorectal
cancers (left lower panel). Kaplan–Meier survival graph for colorectal cancer patients with lower (blue line) or higher (red
line) expression levels of Snail and Zeb1 on the basis of their transcript abundance at an optimal threshold, indicated by
percentile number (right panel). In the heatmap, red denotes higher relative expression, whereas green indicates lower
relative expression, with degree of color saturation reflecting the magnitude of the log expression signal; (b) Immunoblot
analysis of Snail, Zeb1 and E-cadherin in HCT116 after siRNA-mediated knockdown of Snail and Zeb1. Tubulin was used
as loading control. Representative blots are shown from at least two independent experiments; (c) Quantitative PCR (qPCR)
analysis of Snail and Zeb1 after siRNA-mediated knockdown of Snail and Zeb1 in HCT116 (* p < 0.05, ** p < 0.01 compared
with siControl, t-test); (d) In HCT116 of which Snail and Zeb1 were knocked out, respectively, by CRISPR-Cas9 systems,
qPCR analysis of Snail and Zeb1 was performed after siRNA-mediated knockdown of Snail and Zeb1 (* p < 0.05, ** p < 0.01
compared with siControl, t-test).
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2.2. Snail and Zeb1 Are Regulated by Shared miRs
Previously, we and others reported that 3′ UTRs of Snail and Zeb1 contain tumor
suppressive miR binding sites miR-34a and miR-200, respectively (Figure 2a) [3,17–20].
To examine whether these tumor suppressive miRs are involved in the UTR interaction
between Snail and Zeb1, we next overexpressed miR-34a or miR-200 together with lu-
ciferase vectors having a Snail or Zeb1 UTR, then measured the reporter activity and
protein abundance in HCT116 cells. As expected, miR-34a or miR-200 suppressed Snail and
Zeb1 UTR activity along with their endogenous protein abundances (Figure 2b,c). Notably,
miR-200 also suppressed Snail’s UTR activity and protein abundance, although there is
no putative binding site for miR-200, indicating that those UTRs competitively bind to
tumor suppressive miRs. To directly test this notion, we overexpressed the miR-34a or
miR-200 sponge together with the Snail or Zeb1 UTR luciferase constructs and measured
the reporter activity. Interestingly, the miR-34a or miR-200 sponge increased the Snail
and Zeb1 UTR activities as well as the endogenous protein abundance (Figure 2d,e). The
overexpression of the miR-34a or miR-200 sponge increased the migratory potential and
therapeutic resistance against the paclitaxel of HCT116 cells (Figure 2f,g).
Given the concordant transcript abundance of Snail and Zeb1, we next examined the
miR-34a and miR-200 abundance in colon cancer samples. In TCGA samples, we found
the miR-34a and miR-200 abundance to be highly correlated in the COADREAD samples
(Figure 2h). This correlation was also found in BRCA, LUAD, LUSC and HNSC (Figure S2).
These results suggest that miR-34a and miR-200 regulate each other similarly to the UTRs
of Snail and Zeb1. To explore this possibility, we overexpressed the tumor suppressive miR
expression vectors or sponge vectors and determined the transcript abundances. Indeed,
the miR-34a and miR-200 abundances were tightly correlated (Figure 2i,j).
2.3. UTRs of Snail and Zeb1 Can Be Regulatory Factors in a ceRNA Network
As the UTR transcript of EMT genes and tumor suppressive miRs were tightly co-
regulated, we hypothesized that the UTRs of Snail and Zeb1 compete with tumor sup-
pressive miRs and are reciprocally regulated by a trans-regulatory network (Figure 3a).
Supporting this notion, the overexpression of a Snail or Zeb1 UTR decreased both the
miR-34a and miR-200 abundance while increasing the migratory potential of HCT116 cells
(Figure 3b,c). To determine whether the miRs are critically involved in the trans-regulatory
network, we next overexpressed the EMT UTR constructs in parental or Dicer-null HCT116
cells, then measured the transcript and endogenous protein abundance of Snail and Zeb1.
The trans-regulation of the Snail and Zeb1 UTR transcript disappeared and endogenous
protein abundances were unchanged in Dicer-null HCT116 cells (Figure 3d,e). To examine
the possibility of an endogenous protein of Snail and Zeb1, we next constructed mCherry
expression vectors with UTRs of Snail or Zeb1 (Figure 3f). Co-transfecting mCherry in
combination with luciferase expression vectors in Snail-null or Zeb1-null cells, we observed
trans-regulation between the UTRs of Snail and Zeb1 independent of a protein-coding func-
tion (Figure 3g). The overexpression of Snail or Zeb1 UTRs was sufficient to increase the
migratory potential of HCT116 cells (Figure 3h). These results support a trans-regulatory
network between Snail and Zeb1 independent of the protein-coding function via tumor
suppressive miRs, at least in part.
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Figure 2. Snail and Zeb1 shared regulatory miR-34a and miR-200: (a) Potential matching target sites of miR-34a and miR-200
in the UTR regions of Snail and Zeb1; (b) Snail and Zeb1 UTR reporter activity in the HCT116 cells that were transient
transfected pMSCV-miR-34a or miR-200 expression vectors. Reporter activity was normalized to the activity of SV40 Renilla
(** p < 0.01 compared with control, t-test); (c) Immunoblot analysis of endogenous Snail and Zeb1 level after transfection
of miR-34a or miR-200 vectors. Representative blots are shown from at least two independent experiments; (d) Snail and
Zeb1 UTR reporter activity in HCT116 cells transfected with miR-34a or miR-200 sponge vector (** p < 0.01 compared with
control, t-test); (e) Immunoblot analysis of endogenous Snail and Zeb1 level after inhibition of miR-34a or miR-200 by the
transfection of sponge vector. Representative blots are shown from at least two independent experiments; (f) Representative
migration images in HCT116 cells transfected with miR sponge vector (upper panel). Migratory activities after function loss
of miR-34a and miR-200. Results are representative of five independent experiments (lower) (* p < 0.05 compared with
vector, Mann–Whitney test); (g) Clonogenic survival assay against paclitaxel in HCT116 cells with transfection of miRs
overexpression vector or miRs sponge vector (* p < 0.05 compared with control, Mann–Whitney test); (h) Unsupervised
hierarchical clustering based on miR-34a and miR-200 expression profiles (right panel) and Pearson correlation scatter plots
(left panel) of miR-34a and miR-200 transcript in colorectal cancers; (i,j) Quantitative PCR analysis of miR-34a or miR-200;
(i) After transfection with an miR-34a and miR-200 expression vector and (j) After transfection with miR-34a or miR-200
sponge vector (** p < 0.01 compared with control, t-test).
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Figure 3. UTRs could play a role in ceRNA regulation: (a) Proposed schematic model of regulation between a ceRNA
set and miR family; (b) Relative miR-34a and miR-200 expression levels in HCT116 cells following transfection with
UTR expression vector of Snail and Zeb1; (c) qPCR analysis of Snail and Zeb1 mRNA expression in HCT116 wt and
Dicer-null cells expressing Snail and Zeb1 UTR; (d) Immunoblot analysis of Snail and Zeb1 in HCT116 wt and Dicer-null
cells expressing Snail and Zeb1 UTR (** p < 0.01 compared with vector control, t-test). Representative blots are shown from
at least two independent experiments; (e) Representative migration images (left panel) and the number of migration cells
(right panel) in HCT116 cells expressing Snail and Zeb1 UTR. The number of migration cells. Results are representative of
five independent experiments (* p < 0.05 compared with control, Mann–Whitney test); (f) Schematic representation of the
experimental ceRNA effects on UTRs; (g) Luciferase activity in Snail or Zeb1-null HCT116 cells transfected with control or
UTR vector (** p < 0.01 compared with control, t-test); (h) Representative migration images (left panel) and the number of
migration cells (right panel) in Snail or Zeb1-null HCT116 cells (* p < 0.05 compared with control, Mann–Whitney test).
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2.4. UTRs of Snail and Zeb1 Induce Cancer Stem Cell-Like Properties
It is well known that EMT induces the ‘stemness’ properties of cancer cells, including
resistance to apoptosis, self-renewal, metabolic rewiring and survival of cancer stem
cells [2,3,17,21–25]. To validate that the non-coding UTR of an EMT gene is functional,
we generated inducible cells of a Snail or Zeb1 UTR in HCT116 cells to examine whether
UTR expression affects anchorage-independent growth in a soft-agar assay. Interestingly,
the inducible expression UTR of Snail or Zeb1 increased the number of spherical colonies
compared to the negative control (Figure 4a). Furthermore, the overexpression of the UTR
of EMT genes increased the expression of CD44, a marker of colorectal cancer stem cells
(Figure 4b) [22–24], as well as therapeutic resistance against paclitaxel (Figure 4c) [26]. In
protein coding null cells of Snail or Zeb1, the overexpression of UTR was sufficient to
increase therapeutic resistance (Figure 4d). These results indicate that the UTRs of EMT
genes are functionally independent of the protein coding function of Snail or Zeb1. To
examine the reciprocal interaction between the Snail and Zeb1 UTR in vivo, we generated
inducible cells of the Snail or Zeb1 UTR in 293 cells, then designed an experiment to
examine the UTR interaction (Figure 4e). Indeed, the in vivo induction of the Snail or Zeb1
UTR increased the protein abundance as well as the transcript abundance in cis (Snail UTR
vs. Snail transcript or protein; Zeb1 UTR vs. Zeb1 transcript or protein) and in trans (Snail
UTR vs. Zeb1 transcript or protein; Zeb1 UTR vs. Snail transcript or protein) (Figure 4f,g).
2.5. Genome-Wide ceRNA Network of EMT Genes
Given our observations of a trans-regulatory network between Snail and Zeb1, we next
expanded our ceRNA network search to EMT genes genome-wide. We chose 100 predicted
co-target genes of miR-34a and miR-200 using TargetScan (http://www.targetscan.org
(accessed on 9 February 2018)) according to the score sum of both miRs (Table S1) and
analyzed the correlation of those co-target genes in COADREAD samples. Interestingly, we
found three gene sets clustered in clinical samples (Figure 5a). Furthermore, the Snail and
Zeb1 transcripts were segregated, together with 21 other transcripts (Figure S3). Analyzing
the transcript abundance of those genes and tumor suppressive miRs, we found transcript
abundance to be inversely correlated with that of miR-34a and miR-200 (Figure 5b). We next
screened the mRNA transcript abundance of those genes, choosing several genes expressed
in HCT116 cells. We then knocked down Snail or Zeb1 using siRNA and examined the
transcript abundance of those genes. Indeed, transcript abundance was suppressed by
either a Snail or Zeb1 knockdown (Figure 5c). These results suggest the existence of a
genome-wide trans-regulatory ceRNA network of EMT genes independent of the coding
function of transcripts.
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Figure 4. UTRs induce cancer stem cell phenotype and therapeutic resistance: (a) Representative images (left panel) and
colony number (right panel) of UTR-expressing HCT116 cells grown in soft agarose. Cell lines were transduced with
the Tet-inducible UTR expressing lentivirus, then treated with or without doxycycline (* p < 0.05 compared with control,
Mann–Whitney test); (b) Flow cytometry analysis of CD44 protein in Snail UTR (left panel) or Zeb1 UTR (right panel)
expressing HCT116 cells; (c) Clonogenic survival assay of HCT116 after transfection of Snail and Zeb1 UTR against 5 nM
paclitaxel treatment (* p < 0.05 compared with control, Mann–Whitney test). Colonies of more than 50 cells were counted
after crystal violet staining; (d) Clonogenic survival assay against paclitaxel treatment after transfection of UTR in Snail and
Zeb1-knocked out HCT116 (* p < 0.05 compared with control, Mann–Whitney test); (e) Schematic diagram of experimental
design in vivo. A doxycycline-inducible 293-UTR cell line was used. Once tumor size reached 1000 mm3, we induced UTR
with administration of doxycycline (5 mpk) 3 times; (f) Snail and Zeb1 immunohistochemical staining; (g) Relative mRNA
expression level of Snail and Zeb1 (** p < 0.01 compared with control, t-test).
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Figure 5. Genome-wide EMT ceRNA network: (a) Genome-wide correlation map associated with 100 miR-34a and miR-200
co-target genes; (b) Unsupervised hierarchical clustering of mRNA and tumor suppressive miRs associated with miR-34a
and miR-200 co-target genes. In the heatmap, red denotes higher relative expression, whereas green indicates lower relative
expression, with degree of color saturation reflecting the magnitude of the log expression signal; (c) qPCR of candidate
genes subject to ceRNA regulation by Snail and Zeb1 in HCT116 cells (* p < 0.01 compared with control, t-test).
3. Discussion
EMT in cancer is a well-known biological program for cancer progression, accompa-
nied by a loss of cell polarity, a reduced expression of basement membrane components,
an enhanced catabolic metabolism and an increased propensity for metastasis [25,27–30].
While the EMT promotes phenotypic transition from epithelial to mesenchymal, transiently
or stably, recent findings indicate that it also plays a critical role in cancer stemness, the
inflammatory response and the acquisition of drug resistance [21]. Many EMT-promoting
transcription factors, such as Snail (SNAI1), Slug (SNAI2), TWIST (TWIST1) and Zeb1
(ZEB1), can suppress epithelial genes directly or indirectly [3,17,31–34]. The expression of
these genes is regulated by a transcriptional and post-translational modification within
oncogenic signaling pathways [4,5,17,31,32]. For example, the canonical Wnt pathway
stabilizes the Snail protein by the inhibition of ubiquitination and TGF-β promotes the
transcription of EMT genes [3,28,35]. Recent studies have demonstrated that tumor sup-
pressive miR-34a and miR-200 repress Snail and Zeb1 expression via direct targeting of
their respective UTRs [3,17–20,36,37]. Although most EMT studies have been performed
based on the protein-coding function of those genes, the role of the UTR of EMT-inducers
is not well-understood. As the ceRNA hypothesis introduces an additional interesting
layer within the biological network [10,12,13,38], we explored the role of a trans-regulating
ceRNA network related to EMT genes and tumor suppressive miRs.
In this study, we found an miR-mediated trans-regulation ceRNA network involving
Snail and Zeb1 UTRs resulting in a concordant abundance of EMT genes. Our observations
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have several implications for cancer progression and the therapeutic resistance of cancer
cells. First, the UTR of an mRNA transcript is largely regarded as a negative cis-regulator of
protein expression. We found that the UTRs of EMT genes compete with tumor suppressive
miRs and function as a positive trans-regulator of transcript and protein abundance. For
example, the overexpression of a Snail or Zeb1 UTR without a coding gene increased
endogenous Snail and Zeb1 protein expression by competing with tumor suppressive miRs.
Second, the interaction between an miR and a UTR is considered a weaker interaction
biologically. However, we found that EMT transcripts were inversely correlated with tumor
suppressive miRs in many sets of clinical cancer samples, indicating that ceRNA networks
are more influential than previously assumed. Third, a ceRNA network of non-coding
UTRs and miRs plays a role in the therapeutic resistance and EMT phenotype of cancer cells
independent of the protein coding function. In turn, the non-coding RNA function is not
confined to the negative regulation of gene expression. Lastly, we found a genome-wide
ceRNA network of the co-target genes of tumor suppressive miRs. Note that only a few
negative correlations were found among the co-target genes of tumor suppressive miRs
(Figure 5b). Although we only chose 100 genes according to the sum score (Table S1), the
trans-regulatory network consists of several layers of reciprocal interactions, broadening the
biological function of non-coding RNA. For example, we found another gene set including
the tumor suppressor PTEN, suggesting that EMT genes are indirectly connected with
PTEN via a ceRNA network.
Transcriptional landscape studies of functional DNA elements and comparative stud-
ies have revealed that a majority of transcripts consist of non-coding RNA harboring diverse
and significant gene regulatory functions, especially in human diseases and cancer [39,40].
While we only exemplified the non-coding UTRs of EMT genes and tumor suppressive
miRs, the trans-regulating ceRNA network is also regulated by other non-coding RNAs,
such as long non-coding RNAs (lncRNAs), circular RNAs, pseudogenes and anti-sense
transcripts [13].
In conclusion, we demonstrate that Snail and Zeb1 expression, in terms of transcript
abundance as well as protein expression, is coordinated via tumor suppressive miRs in
human cancer. As Snail and Zeb1 are well-known independent EMT inducers, our obser-
vations provide a trans-regulatory non-coding RNA network between EMT genes beyond
the protein coding function. Further, the ceRNA network is functional in therapeutic resis-
tance and tumor progression. Although our study only focused on EMT genes and tumor
suppressive miRs, further study is needed to broaden our understanding of oncogenic or
tumor suppressive ceRNA networks in human cancer.
4. Materials and Methods
4.1. Cells and Constructs
HCT116 wt (parental) and Dicer-null cells were kindly provided by Dr Vogelstein’s
lab as described previously [3,31]. They were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Lonza, Basel, Switzerland) supplemented with 10% fetal bovine serum
(FBS) (Life Technologies, Carlsbad, CA, USA) [4,41]. miR and UTR expression vectors
were described previously [11,14]. To create the miR-34a and miR-200 sponge vector
with three perfectly complementary miRNA binding sites, two complementary oligos (an
upper and lower strand) were synthesized, annealed and inserted between the BamHI
and NotI sites or Not1 and Xba1 sites into pcDNA3.1-lucifrease vector and pcDNA3.1-
mCherry vector. The miR-34 and 200 sponge sequence were miR-34a sponge oligo 5′-
GATCCACAACCAGCTAAGACACTGCCAAACAATCAGCTAATGACACTGCCTAAAG
CAATCAGCTAACTACACTGCCTGC and miR-200 sponge oligo 5′-GGCCGCACAACCAG
CTAAGACACTGCCAAACAATCAGCTAATGACACTGCCTAAAGCAATCAGCTAACTA
CACTGCCTT. Tetracycline-inducible Snail and Zeb1 UTR expression vectors were gen-
erated with the pTRIPZ lentiviral system (Open Biosystems, Huntsville, AL, USA) by
replacing RFP. A pTRIPZ-Snail and Zeb1 UTR expression vector was used to generate
retroviral stocks in 293 cells for infecting 293A and HCT116 cells. Stable UTR transfec-
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tants were obtained after selection with 1.0 µg/mL puromycin (Sigma, St. Louis, MO,
USA). To obtain knockdown of Snail or Zeb1 expression in HCT116 cell, corresponding
CRISPR/Cas9-assisted plasmids were used. Expression vectors for guide RNA (pRGEN-
sgRNA-U6) and Cas9 gene (pRGEN-Cas9-CMV) were purchased from ToolGen (ToolGen
inc., Seoul, Korea). Cells were seeded into a 96-well plate to isolate cell colonies at 48 h
after CRISPR plasmid treatment. Knockout cells were screened using Western blot and
genomic DNA sequencing.
4.2. Snail and Zeb1 UTR Reporter Assays
The predicted miR-34a and miR-200 target sites in the 3′UTR of Snail and Zeb1 were
identified as described previously [11,14]. A luciferase expression construct with multiple
cloning sites for UTRs was used as described previously [3,14]. The 3′UTRs of Snail and
Zeb1 were amplified from the genomic DNA of MCF-7 cells and sub-cloned into the BamH1
and NotI sites downstream of luciferase. For targeting of endogenous miR-34a and miR-200,
cells were transiently transfected with 3′ UTR reporter constructs (1–5 ng) and miR vectors
that induce expression or suppression (500 ng) using Lipofectamine 2000 (Invitrogen,
Waltham, MA, USA). The activity of 3′ UTR reporter constructs was normalized to the
activity of the cotransfected SV40-renilla luciferase construct (2 ng) (Promega, Madison,
WI, USA). Cells were lysed 48 h after transfection and the relative ratio of renilla luciferase
to firefly luciferase activity was measured in a dual luciferase assay (Promega, Madison,
WI, USA).
4.3. Quantitative-PCR (qPCR)
HCT116 cells were transiently transduced with siRNA for Snail and Zeb1. SiRNA
duplexes directed against human Snail and Zeb1 were obtained from Santa Cruz Biotechnol-
ogy. The relative expression levels of Snail, Zeb1, CORO1C, RGS17, ELMOD1, IDS and QKI
transcript were determined using real time quantitative PCR as described previously [14].
Briefly, total RNA of the cells was isolated with Trizol (Invitrogen, Waltham, MA, USA),
and cDNA was synthesized using random hexamer reverse transcription primer (Intron,
Seoul, Korea). Transcript levels were detected using the 7300 Real-Time PCR System and
SYBR Green (Applied Biosystems, Foster, CA, USA) with qPCR primer (Table 1) and both
then normalized to the levels of GAPDH; the relative log2 expression levels in cancer tissue
compared with paired normal tissue were then calculated. For quantitative analysis of
mature miR-34a and miR-200 levels, human TaqMan miRNA assay kits (Applied Biosys-
tems, assay ID 000426 for miR-34a, ID 000502 for miR-200 and ID001973 for U6 snRNA,
Foster, CA, USA) were used for reverse transcription with specific primers and qPCR was
performed with corresponding probes (n = 3). The expression of mature miR-34a and
miR-200 ∆Ct values from each sample were calculated by normalizing with U6 expression
values.
4.4. Western Blot Analysis
The protein levels of Snail and Zeb1 were detected using Western blot analysis of
whole cell lysate with Triton X-100 with antibodies direct E-cadherin (610181, Invitrogen,
Waltham, MA, USA), Snail (3895s, Cell Signaling Technology, Danvers, MA, USA), Zeb1
(3396, Cell Signaling Technology, Danvers, MA, USA) and Tubulin (Labfrontier Co., Ltd.,
Seoul, Korea).
4.5. Transwell Assay
For migration assays, HCT116 or Snail or Zeb1 null HCT cells by CRISPR-Cas9
were transfected with 3′ UTR vectors and miR vectors that induce overexpression or
suppression of miRs with Lipofectamine. After 24 h, cells were trypsinized, 105 cells were
seeded into Transwell inserts (5.0 µm pore) (BD Biosciences, Palo Alto, CA, USA), and
the number of cells migrating to the basal side of the membrane insert was determined at
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72 h. Migrated cells were calculated as area by Image J 1.52 software (National Institutes of
Health, Bethesda, MD, USA) through the particle analysis method.
Table 1. qPCR primer sequence.
Gene Accession Number Primer Sequences from 5′ to 3′
Snail NM_005985 Forward TCTCTGAGGCCAAGGATCTC
Reverse CTTCGGATGTGCATCTTGAG
Zeb1 NM_001128128 Forward AGACATGTGACGCAGTCTGG
Reverse TTGCAGTTTGGGCATTCATA
CORO1C NM_014325 Forward GAAAGCACATGAAGGAGCAAG
Reverse TGCATATTTTTCGGATTCCAG
RGS17 NM_012419 Forward AGGTCCTAGAGGAATGCCAAA
Reverse TCTGTTCGGAGGAACTCTCTG
ELMOD1 NM_018712 Forward ATGGGAGAAGAAAAGGATGGA
Reverse TGGGGCGATATTGTAGAAATG
IDS NM_000202 Forward CCCATGTTCCCCTGATATTCT
Reverse CACAAGTTCCACAAGGTCCAT
QKI NM_006775 Forward TCCGAGGCAAAGGCTCAATGAG
Reverse GCTCTGTTCTGAGCATCTTCCAC
4.6. Colony Formation Assay and Soft Agar Assay
For drug resistance assay, colony formation assays were performed with 3′ UTR vector,
miR expression or suppression vector transfected cells. The 5 × 104 cells were seeded in
6-well plates. After 3 days of exposure to the 5 µM paclitaxel, the cells were washed with
PBS and cultured in normal culture medium for an additional 10–14 days to determine
clonogenic survival. After crystal violet (0.5% w/v) staining, colonies of more than 50 cells
were counted under stereomicroscope. The number of colonies in 5 randomly chosen fields
was determined under high power stereomicroscope. Soft agar colony formation assay
was performed as described previously [42]. Briefly, Tet-inducible UTR expression HCT116
was suspended at 1 × 104 cells per 6-well plate with 1 mL of 0.3% low-melting agar in
2X DMEM containing 20% FBS and overlaid on a layer of 1 mL of 1% agar in the same
medium. After 2 weeks of incubation, viable colonies that contained >50 cells were counted
from five fields with a stereomicroscope. Representative colonies were photographed, and
two independent experiments were performed.
4.7. Flow Cytometry
Cells were dissociated with trypsin and resuspended in PBS with 3% BSA. Cells were
labeled with FITC (fluorescein isothiocyanate) conjugated monoclonal anti-CD44 antibody
(BD Biosciences, Palo Alto, CA, USA) at 4 ◦C for 30 min. Analysis was performed using a
BD FACS Aria II.
4.8. In Vivo Xenograft Assay
Female athymic nude mice (6-week-old) were used for xenograft assays into flank
subcutaneous tissue. A total of 293 cells expressing Tet-inducible UTR (1 × 106) were
resuspended in 100µL of PBS and injected into flank subcutaneous tissue. When the
tumors reached an average of 1000 mm3, mice were given intraperitoneal administration
of 5 mpk doxycycline three times. The mice were sacrificed, and the tumors were extracted
for paraffin-embedding. Tissue lysate was isolated using Trizol from tumor cryosections.
Transcript levels of Snail and Zeb1 in tumor samples were detected using qPCR.
4.9. Gene Expression Analysis of Clinical Samples
Publicly available mRNASeq and miRNASeq data including long-term survival in-
formation from TCGA was downloaded (https://gdac.broadinstitute.org (accessed on
2 February 2017)). The dataset (data version 2016_01_28) included colorectal adenocarci-
noma (COADREAD, mRNA 623 samples, miRNA 295 samples, mutation 223 samples),
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breast cancer (BRCA, mRNA 1093 samples, miRNA 755 samples, mutation 981 samples),
lung adenocarcinoma (LUAD, mRNA 515 samples, miRNA 450 samples, mutation 230 sam-
ples), lung squamous cell carcinoma (LUSC, mRNA 501 samples, miRNA 342 samples,
mutation 178 samples) and head and neck squamous cell carcinoma (HNSC, mRNA
520 samples, miRNA 486 samples, mutation 279 samples). The illuminahiseq_rnaseqv2-
RSEM_genes_normalized (MD5) was log2 transformed. Mutational information and
clinical data for survival analysis were obtained using Mutation_Packager_Calls (MD5) in
the level 3 dataset and Clinical_Pick_Tier1 (MD5) in the level 4 dataset. For unsupervised
hierarchical cluster analysis, Ward linkage method was used together with the Pearson
distance for both sample and gene clustering. For survival analysis, low and high expres-
sion groups were determined from the lowest p value between 10–90 percentile. The high
and low abundance subsets were determined based on the median transcript abundance
of Snail and Zeb1, yielding groups with the most significant differences in survival based
on the log-rank test described previously [42,43]. The R package was used to generate a
Kaplan–Meier plot (survival), correlation plot (corrplot) and heatmap plot (gplots).
4.10. Statistical Analysis
Statistical significance of reporter assays and qPCR were determined using an inde-
pendent sample t-test, and Mann–Whitney test was performed to determine significant dif-
ferences in colony formation and Transwell assay among group means for non-parametric
statistical hypothesis using IBM SPSS Statistics (Released 2017 for windows, Version 25.0
Armonk, NY: IBM Corp, USA). Differences were considered significant when the p value
was less than 0.05 or 0.01 as indicated in the text.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/ijms22179589/s1. Figure S1: Reciprocal interaction between Snail and Zeb1, Figure S2: The
correlation of miR-34a and miR-200 family in BRCA, LUAD, LUSC and HNSC, Figure S3: Co-target
genes of Snail and Zeb1 in COADREAD samples, Figure S4: Uncropped images of all the Western
blot data, Table S1: Correlation score between miRs and mRNAs.
Author Contributions: N.H.K. and S.H.S. performed the main experiments; Y.H.C., K.H.H., J.S.Y.,
H.S. and S.Y.C. supported the in vitro experiments; S.B.C. and I.L. performed the bioinformatics
analysis; H.S.K. and J.I.Y. planned all the experiments, analyzed the data and wrote the manuscript.
All authors have read and agreed to the published version of the manuscript.
Funding: This work was supported by grants from the National Research Foundation of Korea (NRF-
2017R1A2B3002241, NRF-2018M3A9E2022820, NRF-2019R1A2C2084535 and NRF-2021R1A2C3003496)
funded by the Korea government (MSIP).
Institutional Review Board Statement: The animal study was reviewed and approved by the
Animal Care Committee of the Yonsei University College of Dentistry.
Informed Consent Statement: Not applicable.
Data Availability Statement: The data presented in this study are available in this article and the
Supplementary Materials.
Acknowledgments: We thank E. Tunkle for the preparation of the manuscript and K.Y. Kim for the
statistical analysis.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Ota, I.; Li, X.Y.; Hu, Y.; Weiss, S.J. Induction of a mt1-mmp and mt2-mmp-dependent basement membrane transmigration
program in cancer cells by snail1. Proc. Natl. Acad. Sci. USA 2009, 106, 20318–20323. [CrossRef] [PubMed]
2. Kurrey, N.K.; Jalgaonkar, S.P.; Joglekar, A.V.; Ghanate, A.D.; Chaskar, P.D.; Doiphode, R.Y.; Bapat, S.A. Snail and slug mediate
radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian
cancer cells. Stem. Cells 2009, 27, 2059–2068. [CrossRef]
3. Kim, N.H.; Kim, H.S.; Li, X.Y.; Lee, I.; Choi, H.S.; Kang, S.E.; Cha, S.Y.; Ryu, J.K.; Yoon, D.; Fearon, E.R.; et al. A p53/mirna-34 axis
regulates snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol. 2011, 195, 417–433. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2021, 22, 9589 14 of 15
4. Yook, J.I.; Li, X.Y.; Ota, I.; Hu, C.; Kim, H.S.; Kim, N.H.; Cha, S.Y.; Ryu, J.K.; Choi, Y.J.; Kim, J.; et al. A wnt-axin2-gsk3beta cascade
regulates snail1 activity in breast cancer cells. Nat. Cell Biol. 2006, 8, 1398–1406. [CrossRef] [PubMed]
5. Joseph, J.V.; Conroy, S.; Tomar, T.; Eggens-Meijer, E.; Bhat, K.; Copray, S.; Walenkamp, A.M.; Boddeke, E.; Balasubramanyian,
V.; Wagemakers, M.; et al. Tgf-beta is an inducer of zeb1-dependent mesenchymal transdifferentiation in glioblastoma that is
associated with tumor invasion. Cell Death Dis. 2014, 5, e1443. [CrossRef]
6. Chang, C.J.; Chao, C.H.; Xia, W.; Yang, J.Y.; Xiong, Y.; Li, C.W.; Yu, W.H.; Rehman, S.K.; Hsu, J.L.; Lee, H.H.; et al. P53 regulates
epithelial-mesenchymal transition and stem cell properties through modulating mirnas. Nat. Cell Biol. 2011, 13, 317–323.
[CrossRef]
7. Friedman, R.C.; Farh, K.K.; Burge, C.B.; Bartel, D.P. Most mammalian mrnas are conserved targets of micrornas. Genome Res.
2009, 19, 92–105. [CrossRef]
8. Guo, H.; Ingolia, N.T.; Weissman, J.S.; Bartel, D.P. Mammalian micrornas predominantly act to decrease target mrna levels. Nature
2010, 466, 835–840. [CrossRef]
9. Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human
genes are microrna targets. Cell 2005, 120, 15–20. [CrossRef]
10. Liu, Y.; Xue, M.; Du, S.; Feng, W.; Zhang, K.; Zhang, L.; Liu, H.; Jia, G.; Wu, L.; Hu, X.; et al. Competitive endogenous rna is an
intrinsic component of emt regulatory circuits and modulates emt. Nat. Commun. 2019, 10, 1637. [CrossRef] [PubMed]
11. Lee, I.; Ajay, S.S.; Yook, J.I.; Kim, H.S.; Hong, S.H.; Kim, N.H.; Dhanasekaran, S.M.; Chinnaiyan, A.M.; Athey, B.D. New class
of microrna targets containing simultaneous 5′-utr and 3′-utr interaction sites. Genome Res. 2009, 19, 1175–1183. [CrossRef]
[PubMed]
12. Sumazin, P.; Yang, X.; Chiu, H.S.; Chung, W.J.; Iyer, A.; Llobet-Navas, D.; Rajbhandari, P.; Bansal, M.; Guarnieri, P.; Silva, J.; et al.
An extensive microrna-mediated network of rna-rna interactions regulates established oncogenic pathways in glioblastoma. Cell
2011, 147, 370–381. [CrossRef]
13. Tay, Y.; Rinn, J.; Pandolfi, P.P. The multilayered complexity of cerna crosstalk and competition. Nature 2014, 505, 344–352.
[CrossRef]
14. Kim, N.H.; Kim, H.S.; Kim, N.G.; Lee, I.; Choi, H.S.; Li, X.Y.; Kang, S.E.; Cha, S.Y.; Ryu, J.K.; Na, J.M.; et al. P53 and microrna-34
are suppressors of canonical wnt signaling. Sci. Signal. 2011, 4, ra71. [CrossRef] [PubMed]
15. Cha, Y.H.; Kim, N.H.; Park, C.; Lee, I.; Kim, H.S.; Yook, J.I. Mirna-34 intrinsically links p53 tumor suppressor and wnt signaling.
Cell Cycle 2012, 11, 1273–1281. [CrossRef]
16. Mavrakis, K.J.; Wendel, H.G. Targetscreen: An unbiased approach to identify functionally important microrna targets. Cell Cycle
2010, 9, 2080–2084. [CrossRef]
17. Burk, U.; Schubert, J.; Wellner, U.; Schmalhofer, O.; Vincan, E.; Spaderna, S.; Brabletz, T. A reciprocal repression between zeb1 and
members of the mir-200 family promotes emt and invasion in cancer cells. EMBO Rep. 2008, 9, 582–589. [CrossRef]
18. Park, S.M.; Gaur, A.B.; Lengyel, E.; Peter, M.E. The mir-200 family determines the epithelial phenotype of cancer cells by targeting
the e-cadherin repressors zeb1 and zeb2. Genes Dev. 2008, 22, 894–907. [CrossRef]
19. Shi, K.; Sun, H.; Zhang, H.; Xie, D.; Yu, B. Mir-34a-5p aggravates hypoxia-induced apoptosis by targeting zeb1 in cardiomyocytes.
Biol. Chem. 2019, 400, 227–236. [CrossRef] [PubMed]
20. Gill, J.G.; Langer, E.M.; Lindsley, R.C.; Cai, M.; Murphy, T.L.; Kyba, M.; Murphy, K.M. Snail and the microrna-200 family act in
opposition to regulate epithelial-to-mesenchymal transition and germ layer fate restriction in differentiating escs. Stem Cells 2011,
29, 764–776. [CrossRef] [PubMed]
21. Dean, M.; Fojo, T.; Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5, 275–284. [CrossRef] [PubMed]
22. Chu, P.; Clanton, D.J.; Snipas, T.S.; Lee, J.; Mitchell, E.; Nguyen, M.L.; Hare, E.; Peach, R.J. Characterization of a subpopulation of
colon cancer cells with stem cell-like properties. Int. J. Cancer 2009, 124, 1312–1321. [CrossRef] [PubMed]
23. Ju, S.Y.; Chiou, S.H.; Su, Y. Maintenance of the stemness in cd44(+) hct-15 and hct-116 human colon cancer cells requires mir-203
suppression. Stem Cell Res. 2014, 12, 86–100. [CrossRef]
24. Du, L.; Wang, H.; He, L.; Zhang, J.; Ni, B.; Wang, X.; Jin, H.; Cahuzac, N.; Mehrpour, M.; Lu, Y.; et al. Cd44 is of functional
importance for colorectal cancer stem cells. Clin. Cancer Res. 2008, 14, 6751–6760. [CrossRef]
25. Kim, N.H.; Cha, Y.H.; Lee, J.; Lee, S.H.; Yang, J.H.; Yun, J.S.; Cho, E.S.; Zhang, X.; Nam, M.; Kim, N.; et al. Snail reprograms
glucose metabolism by repressing phosphofructokinase pfkp allowing cancer cell survival under metabolic stress. Nat. Commun.
2017, 8, 14374. [CrossRef]
26. Liu, Y.; Yu, C.; Wu, Y.; Sun, X.; Su, Q.; You, C.; Xin, H. Cd44(+) fibroblasts increases breast cancer cell survival and drug resistance
via igf2bp3-cd44-igf2 signalling. J. Cell. Mol. Med. 2017, 21, 1979–1988. [CrossRef]
27. Mani, S.A.; Yang, J.; Brooks, M.; Schwaninger, G.; Zhou, A.; Miura, N.; Kutok, J.L.; Hartwell, K.; Richardson, A.L.; Weinberg, R.A.
Mesenchyme forkhead 1 (foxc2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc.
Natl. Acad. Sci. USA 2007, 104, 10069–10074. [CrossRef]
28. Peinado, H.; Olmeda, D.; Cano, A. Snail, zeb and bhlh factors in tumour progression: An alliance against the epithelial phenotype?
Nat. Rev. Cancer 2007, 7, 415–428. [CrossRef] [PubMed]
29. Spaderna, S.; Brabletz, T.; Opitz, O.G. The mir-200 family: Central player for gain and loss of the epithelial phenotype. Gastroen-
terology 2009, 136, 1835–1837. [CrossRef]
Int. J. Mol. Sci. 2021, 22, 9589 15 of 15
30. Spaderna, S.; Schmalhofer, O.; Hlubek, F.; Berx, G.; Eger, A.; Merkel, S.; Jung, A.; Kirchner, T.; Brabletz, T. A transient, emt-linked
loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006, 131, 830–840.
[CrossRef]
31. Rosivatz, E.; Becker, I.; Specht, K.; Fricke, E.; Luber, B.; Busch, R.; Hofler, H.; Becker, K.F. Differential expression of the epithelial-
mesenchymal transition regulators snail, sip1, and twist in gastric cancer. Am. J. Pathol. 2002, 161, 1881–1891. [CrossRef]
32. Sanchez-Tillo, E.; Lazaro, A.; Torrent, R.; Cuatrecasas, M.; Vaquero, E.C.; Castells, A.; Engel, P.; Postigo, A. Zeb1 represses
e-cadherin and induces an emt by recruiting the swi/snf chromatin-remodeling protein brg1. Oncogene 2010, 29, 3490–3500.
[CrossRef] [PubMed]
33. Zhang, Y.; Xu, L.; Li, A.; Han, X. The roles of zeb1 in tumorigenic progression and epigenetic modifications. Biomed. Pharmacother.
2019, 110, 400–408. [CrossRef] [PubMed]
34. Cummins, J.M.; He, Y.; Leary, R.J.; Pagliarini, R.; Diaz, L.A., Jr.; Sjoblom, T.; Barad, O.; Bentwich, Z.; Szafranska, A.E.; Labourier,
E.; et al. The colorectal micrornaome. Proc. Natl. Acad. Sci. USA 2006, 103, 3687–3692. [CrossRef]
35. Vincent, T.; Neve, E.P.; Johnson, J.R.; Kukalev, A.; Rojo, F.; Albanell, J.; Pietras, K.; Virtanen, I.; Philipson, L.; Leopold, P.L.; et al. A
snail1-smad3/4 transcriptional repressor complex promotes tgf-beta mediated epithelial-mesenchymal transition. Nat. Cell. Biol.
2009, 11, 943–950. [CrossRef]
36. Perdigao-Henriques, R.; Petrocca, F.; Altschuler, G.; Thomas, M.P.; Le, M.T.; Tan, S.M.; Hide, W.; Lieberman, J. Mir-200 promotes
the mesenchymal to epithelial transition by suppressing multiple members of the zeb2 and snail1 transcriptional repressor
complexes. Oncogene 2016, 35, 158–172. [CrossRef]
37. Ahn, Y.H.; Gibbons, D.L.; Chakravarti, D.; Creighton, C.J.; Rizvi, Z.H.; Adams, H.P.; Pertsemlidis, A.; Gregory, P.A.; Wright,
J.A.; Goodall, G.J.; et al. Zeb1 drives prometastatic actin cytoskeletal remodeling by downregulating mir-34a expression. J. Clin.
Investig. 2012, 122, 3170–3183. [CrossRef] [PubMed]
38. Ebert, M.S.; Neilson, J.R.; Sharp, P.A. Microrna sponges: Competitive inhibitors of small rnas in mammalian cells. Nat. Methods
2007, 4, 721–726. [CrossRef]
39. Djebali, S.; Davis, C.A.; Merkel, A.; Dobin, A.; Lassmann, T.; Mortazavi, A.; Tanzer, A.; Lagarde, J.; Lin, W.; Schlesinger, F.; et al.
Landscape of transcription in human cells. Nature 2012, 489, 101–108. [CrossRef]
40. Kellis, M.; Wold, B.; Snyder, M.P.; Bernstein, B.E.; Kundaje, A.; Marinov, G.K.; Ward, L.D.; Birney, E.; Crawford, G.E.; Dekker, J.;
et al. Defining functional DNA elements in the human genome. Proc. Natl. Acad. Sci. USA 2014, 111, 6131–6138. [CrossRef]
41. Yook, J.I.; Li, X.Y.; Ota, I.; Fearon, E.R.; Weiss, S.J. Wnt-dependent regulation of the e-cadherin repressor snail. J. Biol. Chem. 2005,
280, 11740–11748. [CrossRef]
42. Lee, Y.; Kim, N.H.; Cho, E.S.; Yang, J.H.; Cha, Y.H.; Kang, H.E.; Yun, J.S.; Cho, S.B.; Lee, S.H.; Paclikova, P.; et al. Dishevelled has a
yap nuclear export function in a tumor suppressor context-dependent manner. Nat. Commun. 2018, 9, 2301. [CrossRef]
43. Camarda, R.; Zhou, A.Y.; Kohnz, R.A.; Balakrishnan, S.; Mahieu, C.; Anderton, B.; Eyob, H.; Kajimura, S.; Tward, A.; Krings, G.;
et al. Inhibition of fatty acid oxidation as a therapy for myc-overexpressing triple-negative breast cancer. Nat. Med. 2016, 22,
427–432. [CrossRef] [PubMed]
